Democrats are concerned that the increase in corporate concentration across a wide range of industries, from hospitals and pharmaceutical companies to agribusiness and retail chains, could be stifling competition and innovation and creating monopoly conditions that harm consumers. We will direct federal regulators to review a subset of the mergers and acquisitions that have taken place since President Trump took office, prioritizing the pharmaceutical, health care, telecommunications, technology, and agricultural industries, to assess whether any have increased market concentration, raised consumer prices, demonstrably harmed workers, increased racial inequality, reduced competition, or constricted innovation, and assign appropriate remedies. Democrats will direct regulators to consider potential effects of future mergers on the labor market,
positive towards the national way of life and history, for example pride of citizenship or appeals to patriotism